rs1555894743

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM4_SupportingPM2_Supporting

This summary comes from the ClinGen Evidence Repository: NM_001754.5(RUNX1):c.530_532dup (p.Ile177_Thr178insIle) is an in-frame insertion which affects a residue within the Runt Homology domain (AA 89-294) but does not impact a residue which has been established as a hotspot (PM4_Supporting). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PM2_supporting, PM4_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA16616526/MONDO:0100083/008

Frequency

Genomes: not found (cov: 33)

Consequence

RUNX1
NM_001754.5 inframe_insertion

Scores

Not classified

Clinical Significance

Uncertain significance reviewed by expert panel U:2

Conservation

PhyloP100: 8.01
Variant links:
Genes affected
RUNX1 (HGNC:10471): (RUNX family transcription factor 1) Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
RUNX1-AS1 (HGNC:56821): (RUNX1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
For more information check the summary or visit ClinGen Evidence Repository.
PM4
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RUNX1NM_001754.5 linkuse as main transcriptc.532_533insTCA p.Ile177dup inframe_insertion 6/9 ENST00000675419.1 NP_001745.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RUNX1ENST00000675419.1 linkuse as main transcriptc.532_533insTCA p.Ile177dup inframe_insertion 6/9 NM_001754.5 ENSP00000501943 A1Q01196-8
RUNX1-AS1ENST00000651798.1 linkuse as main transcriptn.661+22611_661+22613dup intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpMay 03, 2016In summary, this variant is a novel sequence change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a RUNX1-related disease. This sequence change duplicates 3 nucleotides in exon 6 of the RUNX1 mRNA (c.530_532dupTCA). This leads to the duplication of 1 amino acid residue in the RUNX1 protein (p.Ile177dup) but otherwise preserves the integrity of the reading frame. -
Uncertain significance, reviewed by expert panelcurationClinGen Myeloid Malignancy Variant Curation Expert PanelSep 25, 2024NM_001754.5(RUNX1):c.530_532dup (p.Ile177_Thr178insIle) is an in-frame insertion which affects a residue within the Runt Homology domain (AA 89-294) but does not impact a residue which has been established as a hotspot (PM4_Supporting). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PM2_supporting, PM4_supporting. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1555894743; hg19: chr21-36231851; API